11歳　男児　ピーナッツアレルギー
経口免疫療法前の経口負荷試験
ピーナッツprotein　16mg（≒ピーナッツ0.06ｇ）
迅速かつ適切な処置を受けるも死亡

In this current report, an 11‐year‐old boy died after an OFC was performed in a hospital setting to confirm peanut allergic reactivity prior to beginning oral immunotherapy (OIT). Severe bronchospasm and cardiovascular failure occurred after a cumulative reactive dose of 16 mg peanut protein. He died despite prompt epinephrine injection and infusion, resuscitation, and ICU admission.
　　（Allergy. 2019;74:1035–1036.）